Casey O'Connell, MD

Trials

Studies that name Casey O'Connell, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:58 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04873102 · Danazol for Treatment of Cytopenias in Patients With Cirrhosis

  University of Southern California · recruiting · Cirrhosis, Liver, Cytopenia · principal investigator
• N/A
  NCT03207854 · Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

  University of Southern California · recruiting · Healthy Subject, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
• Ph2
  NCT03146871 · Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent

  University of Southern California · terminated · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer Research Training and Education Coordination
  P30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Josh Neman-Ebrahim · fiscal years 2000 to 2026
  Named on NCT03207854, NCT03146871